Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bee Venom in Parkinson's Disease
NCT01341431Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2011
- Primary completion
- Dec 2013
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Bee Venom with Placebo (2 arms). Primary endpoint: Unified Parkinson's Disease Rating Scale Part III at 1 year. Started Mar 2011; status: completed.
02
Drugs
apis mellifera venom
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01341431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01341431.